Safety and Efficacy of KPI-121 in Subjects With Postsurgical Inflammation and Pain
Clinical trial NCT02793817 · COMPLETED
Trial details
- NCT number
- NCT02793817
- Sponsor
- Kala Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-01
- Primary completion
- 2017-03-01
- Enrollment
- 520
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.